Products and Services

Erysense Technology

Engineering
and Hardware Development

Microfluidics Development and Production

Erysense Technology

At Cysmic, we recognize the critical role that blood analysis plays in healthcare. It provides invaluable insights into a patient’s well-being, allowing for early detection, monitoring, and personalized treatment of various blood-related diseases and conditions. However, traditional laboratory-based blood testing methods are often time-consuming, expensive, and require specialized equipment and personnel.

To overcome these challenges, we have harnessed the power of microfluidics – a groundbreaking technology that integrates precise control of minute fluid volumes on microscale devices. Combining these technologies with advanced artificial intelligence-based approaches for cell classification, our team of passionate researchers, engineers, and biomedical experts have combined their expertise to develop the Erysense instrument and create a diverse portfolio of microfluidic devices poised to reshape the landscape of blood testing.

The Erysense Technology

Over 25 trillion red blood cells travel through our bodies every minute. Their shape is a highly sensitive parameter for both intrinsic cell properties and external influences. Erysense utilizes red blood cell shape features as a biomarker.
Schematic shapes of red blood cells in flow
Microscopy images of cells recorded by Erysense
The Erysense platform simulates microvascular blood flow in microchannels with a diameter 10X smaller than human hair. Using an automated AI-based cell shape evaluation, Erysense constitutes a fast and robust point-of-care system for patient-centered assessment of blood functionality.

Technology

Over 25 trillion red blood cells travel through our bodies every minute. Their shape is a highly sensitive parameter for both intrinsic cell properties and external influences. Erysense utilizes red blood cell shape features as a biomarker.

Schematic shapes of red blood cells in flow
Microscopy images of cells recorded by Erysense
The Erysense platform simulates microvascular blood flow in microchannels with a diameter 10X smaller than human hair. Using an automated AI-based cell shape evaluation, Erysense constitutes a fast and robust point-of-care system for patient-centered assessment of blood functionality.

Advantages

Small sample volume

Erysense requires only one drop of blood, avoiding the need for specialized personnel for sampling and minimizing patient blood loss.

Analysis on a single-cell level

The intrinsic cell properties and external conditions highly influence the shape of red blood cells. Erysense enables examining such effects on the morphology of individual cells at high throughput.

Versatility

Erysense enables advanced hematological diagnosis, individualized therapy, and in-vitro drug testing.

Advantages

Small sample volume

Erysense requires only one drop of blood, avoiding the need for specialized personnel for sampling and minimizing patient blood loss.

Analysis on a single-cell level

The intrinsic cell properties and external conditions highly influence the shape of red blood cells. Erysense enables examining such effects on the morphology of individual cells at high throughput.

Versatility

Erysense enables advanced hematological diagnosis, individualized therapy, and in-vitro drug testing.

Applications

Blood quality assessment for transfusion medicine

Advanced hematological diagnostics

Blood and cell
research
 

In-vitro testing for drug development

Biomedical technologies, e.g., cell-based drug delivery

Blood quality
assessment for
transfusion
medicine

Advanced
hematological
diagnostics
 
 
Blood and cell
research
 
In-vitro
testing for drug
development
 
Biomedical
technologies, e.g.,
cell-based
drug delivery
Our dedication to quality and reliability ensures that our Erysense device meets the rigorous standards of regulatory bodies, providing healthcare professionals and patients with confidence in their results. We strive for excellence in every aspect of our work, from research and development to manufacturing and customer support.

We invite you to contact us if you want to learn more about our groundbreaking Erysense technology and how it can revolutionize biomedical diagnostics and applications. Contact us today to discover the future of hematological healthcare.

Contact

+49 176 3078 4328

info(at)cysmic.de

Cysmic GmbH
Auf der Trift 1
66127 Saarbrücken

contact us!